TrialPloS one2010

Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients.

Nicholas Funderburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.